Literature DB >> 20513011

Valproic acid administration for hepatic fibrosis: a balance between antifibrotic efficacy and hepatotoxicity.

Yoshihiro Ikura, Yoko Iwasa, Makiko Ueda.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20513011     DOI： 10.1002/hep.23688

Source DB:  PubMed          Journal:  Hepatology        ISSN： 0270-9139            Impact factor:   17.425


× No keyword cloud information.
  4 in total

Review 1.  Hepatoprotective and Anti-fibrotic Agents: It's Time to Take the Next Step.

Authors:  Ralf Weiskirchen
Journal:  Front Pharmacol       Date:  2016-01-07       Impact factor: 5.810

2.  The effect of antifibrotic drugs in rat precision-cut fibrotic liver slices.

Authors:  Inge M Westra; Dorenda Oosterhuis; Geny M M Groothuis; Peter Olinga
Journal:  PLoS One       Date:  2014-04-22       Impact factor: 3.240

3.  Dual Pharmacological Targeting of HDACs and PDE5 Inhibits Liver Disease Progression in a Mouse Model of Biliary Inflammation and Fibrosis.

Authors:  Alex Claveria-Cabello; Leticia Colyn; Iker Uriarte; Maria Ujue Latasa; Maria Arechederra; Jose M Herranz; Laura Alvarez; Jesus M Urman; Maria L Martinez-Chantar; Jesus M Banales; Bruno Sangro; Krista Rombouts; Julen Oyarzabal; Jose J G Marin; Carmen Berasain; Matias A Avila; Maite G Fernandez-Barrena
Journal:  Cancers (Basel)       Date:  2020-12-13       Impact factor: 6.639

Review 4.  Epigenetics in Liver Fibrosis: Could HDACs be a Therapeutic Target?

Authors:  Alex Claveria-Cabello; Leticia Colyn; Maria Arechederra; Jesus M Urman; Carmen Berasain; Matias A Avila; Maite G Fernandez-Barrena
Journal:  Cells       Date:  2020-10-19       Impact factor: 6.600
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.